Skip to main content

WeRide Achieves Record Five Consecutive Wins at China Urban Intelligent Driving Competition

HEFEI, China, May 18, 2026 (GLOBE NEWSWIRE) — At the Hefei round of the Second China Urban Intelligent Driving Competition hosted by D1EV, a leading electric and intelligent vehicle media platform, the Chery Exeed Sterra ES – equipped with WeRide Driving (WRD 3.0) – secured first place with 102.81 points, extending WRD 3.0’s record to five consecutive wins. With this result, WRD 3.0, WeRide’s one-stage end-to-end ADAS solution co-developed with Bosch, becomes the first and only solution in the competition’s history to achieve a five-win streak, reflecting its leading position in the L2++ ADAS segment. In the preliminary round, two WRD 3.0-powered vehicles – the Exeed Sterra ES and the GAC Aion N60 – claimed first and second place respectively. The Hefei event also marked WeRide’s first multi-vehicle entry in a single competition...

Continue reading

Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital

Promising Early Data Strengthens Potential of Novel PET Technology to Advance Development of Lucid-MS for Multiple Sclerosis TORONTO, May 18, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum” or the “Company”), a biopharmaceutical company focused on advancing innovative therapies and technologies, today announced a significant milestone in its collaborative study with Massachusetts General Hospital (MGH): patient enrollment has reached the halfway mark, accompanied by encouraging preliminary imaging results. This pioneering study is designed to validate a novel positron emission tomography (PET) imaging technique capable of directly assessing demyelinated neurons with intact axons and tracking demyelination in patients with multiple sclerosis (MS)—a critical step toward transforming...

Continue reading

Advantest to Showcase Design-to-Test Automation Using Velocity™ Software at VOICE 2026

Flagship Velocity™ Platform Purpose-Built for V93000 to Offer Best-In-Class Software Capabilities for Data Center Applications TOKYO, May 18, 2026 (GLOBE NEWSWIRE) — Advantest Corporation (TSE Prime: 6857), a global leader in semiconductor test solutions, today announced it will showcase the integration of AllianceATE’s flagship Velocity™ software platform with Advantest’s V93000 SoC test system at the VOICE 2026 Developer’s Conference, May 18-20, in Scottsdale, Arizona. Since Advantest’s acquisition of AllianceATE in September 2025, the two teams have been working closely to strategically integrate AllianceATE’s unique software capabilities into the V93000’s software ecosystem. This effort demonstrates a long-term strategy to ensure a seamless customer experience. Velocity™, AllianceATE’s flagship electronic...

Continue reading

Compass Lexecon Adds Leading Competition and Regulatory Economist in London

LONDON, May 18, 2026 (GLOBE NEWSWIRE) — Compass Lexecon, a subsidiary of FTI Consulting, Inc. (NYSE: FCN), today announced the appointment of Nicola Mazzarotto as an Executive Vice President in London. Mr. Mazzarotto has more than 26 years of competition and regulatory economics expertise. He has advised corporate clients across a diverse range of sectors on complex competition matters, merger reviews, regulatory investigations and strategic regulatory planning. “We are delighted to welcome Nicola to Compass Lexecon,” said Justin Coombs, an Executive Vice President and Head of the International Executive Committee at Compass Lexecon. “He brings extensive experience across competition policy, regulation and litigation, and will further strengthen our ability to support clients on complex competition matters.” Mr. Mazzarotto has...

Continue reading

Share repurchase programme: Transactions of week 20 2026

The share repurchase programme runs as from 5 February 2026 and up to and including 29 January 2027 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 3 billion, cf. Corporate Announcement No. 11/2026 of 5 February 2026. The share repurchase programme is initiated and structured in compliance with the Market Abuse Regulation (Regulation (EU) No 596/2014) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”). The following transactions have been made under the program:  Number of shares Average purchase price (DKK) Transaction value (DKK)Accumulated, previous announcement 946,527 904.73 856,356,09711 May 2026 16,067 894.43 14,370,88112 May 2026 13,228 891.10 11,787,50313 May 2026 16,800 896.14 15,055,128Accumulated...

Continue reading

Hexagon Purus ASA: Ex. reverse share split and change of ISIN today

Issuer name: Hexagon Purus ASAEx. date: 18 May 2026Type of corporate action: Reverse share splitReverse share split ratio: 10:1, where ten (10) old shares give one (1) new share. New par value per share: NOK 1New ISIN for the Company’s shares: NO0013751966 This information is published in accordance with the requirements of the Continuing Obligations

Continue reading

Nextensa strengthens balance sheet and advances key developments in Q1 2026

PRESS RELEASE REGULATED INFORMATIONBrussels, 18 May 2026, 07:55 AMNEXTENSA STRENGTHENS BALANCE SHEET AND ADVANCES KEY DEVELOPMENTS IN Q1 2026Brussels, 18 May 2026 – Nextensa delivered a strong first quarter of 2026, marked by key transactions, including the disposal of Gewerbepark Stadlau in Vienna. Following the quarter-end, additional major milestones were achieved, including the sale of The Rock and the B&B Hotel in Cloche d’Or, as well as the obtaining of the urban planning and environmental permit for Lake Side at Tour & Taxis.Q1 2026 higlightsSale of Gewerbepark Stadlau (Vienna) for €35.45 million Net financial debt reduced to €571.8 million Continued strong progress in development pipeline (Cloche d’Or & Tour & Taxis) Net profit increased to €9.6 millionPost quarter-end highlights Forward sale of...

Continue reading

Sampo plc’s share buybacks week 20/2026

Sampo plc, stock exchange release, 18 May 2026 at 8:30 am EEST Sampo plc’s share buybacks week 20/2026 During week 20 (11 May 2026 – 15 May 2026), Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:Market (MIC Code) Daily volume (in number of shares) and weighted average price of the purchased shares, EUR* Aggregated weekly volume (in number of shares) and weighted weekly average price of the purchased shares, EUR*    11/05/2026 12/05/2026 13/05/2026 14/05/2026 15/05/2026 Week 20/2026, totalAQEU Volume 3,335 4,248 2,850 0 3,786 14,219Average price 8.87 8.87 8.89 0.00 9.00 8.91CEUX Volume 159,670 150,727 144,078 0 142,487 596,962Average price 8.89 8.91 8.90 0.00 8.99 8.92TQEX Volume 47,523 46,885 40,441 0 32,934 167,783Average price 8.89 8.92 8.90 0.00 9.00 8.92XHEL Volume 252,296 241,206 263,784 0 194,711 951,997Average...

Continue reading

BW Offshore: First quarter results 2026

First quarter results 2026 HIGHLIGHTSQ1 EBITDA of USD 47.9 million and operating cash flow of USD 43.3 million Robust balance sheet with USD 568 million in available liquidity Q1 cash dividend of USD 0.063 per share BW Opal production restarted, commissioning and practical completion expected mid-2026 Signed FEED with Equinor for Bay du Nord FPSO and established local office in St. John’s Extended BW Catcher contract through 2030 Strategic review progressing Full-year 2026 EBITDA guidance revised to USD 310-340 millionOn BW Opal, the replacement of the compressor dry-gas seals was completed in March. Gas production recommenced in early May after a temporary shutdown during March and April for cleaning the heat exchanger trains. A root cause analysis of the heat exchanger fouling has been completed and is currently under joint review...

Continue reading

Ipsen initiates a new share buy-back program

Ipsen initiates a new share buy-back program PARIS, FRANCE, 18 MAY 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it has appointed an investment services provider to purchase an aggregate number of up to 350,000 Ipsen S.A. shares, representing approximately 0.42% of the share capital, over a maximum period of six months. The shares purchased under this agreement will be allocated mainly to cover Ipsen’s free employee share-allocation plan and its new employee share-ownership plan. This program is made pursuant to the authorization granted by the Company’s Annual General Meeting, held on 13 May 2026. About IpsenWe are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by internal...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.